chapter 1 DNA Biochips — Past, Present, and Future: An Overview -- chapter 2 Three-Dimensional HydroArrays: Novel Microarrays for Genomic and Proteomic Studies -- chapter 3 Biochips in Malaria for Antiparasitic Discovery -- chapter 4 Regional Variations in Intestinal ATP-Binding Cassette Transporter Expression Identified with a Global Error Assessment Model* -- chapter 5 Toxicogenomics in Drug Safety Evaluation: Bridging Drug Discovery and Development -- chapter 6 The Next Generation of Automated Microarray Platforms for a Multiplexed CYP2D6 Assay -- chapter 7 Evaluation of Skeletal Muscle and Adipose Tissue Biopsy Procedures for Microarray-Based Gene-Expression Profiling -- chapter 8 ChIP-on-Chip: Analysis of Genomewide Protein Binding and Posttranslational Modifications -- chapter 9 DNA Microarrays as Functional Genomics Tools for Cancer Drug Discovery -- chapter 10 High-Throughput Microarray Analysis -- chapter 11 Laboratory Automation: Strategies for High-Volume Industrial Microarray Programs -- chapter 12 Association Studies: Practical and Theoretical Considerations for Drug Discovery, Evaluation, and Beyond -- chapter 13 Approaches for Microarray Data Validation -- chapter 14 Microarray Enterprise Information Management: What Is It and Why Is It Important? -- chapter 15 Quality Control of Microarray Data -- chapter 16 Microarray Data Normalization and Transformation -- chapter 17 Amplification Strategies and DNA Biochips -- chapter 18 Ribo-SPIA™, a Rapid Isothermal RNA Amplification Method for Gene Expression Analysis -- chapter 19 Genomics, Transcriptomics, and Proteomics: Novel Detection Technologies and Drug Discovery -- chapter 20 Intellectual Property Issues for DNA Chips and Microarrays -- chapter 21 Biochips: Market Drivers and Commercial Prospects -- chapter 22 A Pharmaceutical Perspective for Microarrays and Biochips: Current-Market Overview and Future Trends